Topic Highlight
Copyright ©2013 Baishideng.
World J Radiol. Mar 28, 2013; 5(3): 126-142
Published online Mar 28, 2013. doi: 10.4329/wjr.v5.i3.126
Figure 1
Figure 1 A 62-year-old man with multifocal hepatocellular carcinoma. A: Baseline contrast enhanced computed tomography (CT) in the arterial phase shows enhancing nodules in segment VIII and IV; B: Contrast enhanced CT after Sorafenib shows decreased tumor enhancement with near complete disappearance of enhancement in some nodules (arrows) and only marginal decreased tumor size.